Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Koninklijke Philips N.V.NYSE: PHG

Gross Profit · Q2 FY2026 · quarter ended Jun 2026

Gross profit growth accelerates

Q2 FY2026 gross profit of €2.15B rose 6.9% year over year, ahead of the +3.6% change in trailing-twelve-month gross profit. Sequentially, it rose 21.7% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.

Context

  • Gross profit amounted to 45.2% of revenue in FY2025, up 2.1 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +6.9% holds above the trailing-twelve-month pace of +3.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
€2.15B+21.7% QoQ
Last fiscal yearDec 2025
€8.06B+3.7% YoY
LTMJun 2026
€8.11B+3.6% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.9%——
1 year+3.7%——
3-year CAGR+3.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

EUR · from the income statement

Latest · FY2025
8.06B EUR
Year-over-year change
+3.7%
4-year CAGR
+3.0%

Gross Profit vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +3.6% is the 9th highest of 10, against a peer median of +14.7%.
  • Gross profit amounts to 45.9% of revenue for PHG, versus a peer median of 67.9%.
PHG Competitors
Gross Profit for PHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Sep 2026$27.55B USD+16.4%+3.3%57.1%
MDTMedtronic plcLTM Jul 2026$25.04B USD+15.4%+4.9%66.7%
BSXBoston Scientific CorporationLTM Jun 2026$14.94B USD+27.8%+21.5%71.2%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$8.69B USD+4.7%+4.7%42.9%
PHGKoninklijke Philips N.V.LTM Jun 2026€8.11B EUR+3.6%+3.9%45.9%
SNNSmith & Nephew plcFY2025$4.21B USD+3.1%+4.4%68.3%
RMDResMed Inc.LTM Jun 2026$3.46B USD+13.2%+13.6%61.2%
LIVNLivaNova PLCLTM Sep 2026$1.02B USD+10.7%+9.9%67.9%
NPCENeuroPace, Inc.LTM Mar 2026$77.93M USD+23.5%+33.4%78.3%
IRMDIRadimed CorporationLTM Mar 2026$66.3M USD+14.7%+15.9%76.8%
Peer median (excluding PHG) —+14.7%+9.9%67.9%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.